证券代码：300387 证券简称：富邦股份 湖北富邦科技股份有限公司投资者关系活动记录表 编号：2023-002 投资者关系活 动类别 □特定对象调研 □分析师会议 □媒体采访 ■业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 （请文字说明其他活动内容） 参与单位名称 及人员姓名 通过全景网路演互动平台参加 2023 年湖北辖区上市公司投资者网上集体 接待日 时间 2023 年 5 月 25 日 14：10-16：35 地点 全景网"全景•路演天下"（http://rs.p5w.net） 上市公司接待 人员姓名 公司董事长兼总经理王仁宗先生，副总经理兼财务负责人万刚先生，副总 经理兼董事会秘书易旻女士 投资者关系活 动主要内容介 绍 公司于 2023 年 5 月 25 日（星期四）14：10-16：35 在"全景·路演天 下"举行 2023 年湖北辖区上市公司投资者网上集体接待日，本次集体接待 采用网络远程的方式举行。问答环节主要内容如下： 【问题 1】请问收购康欣生物的进展情况，预计完成收购时间？ 【回答】公司董事长兼总经理王仁宗：尊敬的投资者，您好！2023 年 3 月，经总经理办公会审议批准， ...

司，纳入公司合并报表范围。当前已经完成了第一次涉及 35%股权转让的 相关工商变更登记，并换发了《营业执照》。2022 年 12 月，湘渝生物全资 子公司广东湘渝科技有限公司通过"高新技术企业"认定。后续项目进展请 您关注公司公告。感谢您的关注，祝您投资愉快！ 【问题 3】请问公司在生物农业的布局有哪些？ 【回答】副总经理、董事会秘书万刚： 尊敬的投资者，您好！为响应当前国家对于节肥减药、农业绿色种植、 保障粮食安全的号召，顺应助剂绿色化、定制肥料绿色化行业发展趋势，公 司在禾本科固氮微生物、节肥减药、绿色种植、生物农药等领域进行业务拓 展，公司在"生物科技"领域主动布局。 公司与湘渝生物达成股权合作，拟收购其 70%股份，助力公司在生物 刺激素、中微量元素与传统肥料相结合的定制肥料的研发创新，为公司微 生物、海藻萃取物与增值肥料的结合、生物发酵等现代生物技术领域提供 技术积累。 证券代码：300387 证券简称：富邦股份 湖北富邦科技股份有限公司投资者关系活动记录表 编号：2023-001 投资者关系活 动类别 □特定对象调研 □分析师会议 □媒体采访 ■业绩说明会 □新闻发布会 □路演活动 □现场参观 □ ...

湖北富邦科技股份有限公司2022年年度报告全文 湖北富邦科技股份有限公司 2022 年年度报告 2023-013 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥246,970,635.49, representing a 25.73% increase compared to ¥196,423,572.57 in the same period last year[3] - Net profit attributable to shareholders was ¥19,021,304.50, up 41.02% from ¥13,488,046.82 year-on-year[3] - Basic earnings per share increased by 31.60% to ¥0.0658 from ¥0.0500 in the same period last year[3] - The increase in sales revenue led to a 29.65% rise in net profit, amounting to ¥1,827.19 million compared to ¥1,409.27 million in the previous year[6] - Operating profit increased to CNY 24,134,897.18, representing a growth of 41.5% from CNY 17,030,376.29 in Q1 2022[25] - Other comprehensive income after tax for Q1 2023 was CNY 5,898,909.43, a recovery from a loss of CNY 10,196,752.74 in the same period last year[25] Cash Flow - The net cash flow from operating activities reached ¥15,477,002.35, a significant improvement of 249.85% compared to a negative cash flow of ¥10,328,119.32 in the previous year[3] - Cash flow from sales of goods and services increased by 29.12% to ¥25,802.71 million, driven by higher sales receipts[7] - Cash inflow from operating activities totaled CNY 260,291,446.14, compared to CNY 200,991,019.10 in Q1 2022, indicating a growth of 29.5%[27] - The net cash flow from financing activities was 6,003,677.20 CNY in Q1 2023, compared to 10,281,863.45 CNY in Q1 2022, representing a decrease of approximately 41.5%[28] - The cash inflow from borrowing in Q1 2023 was 16,000,000.00 CNY, compared to 28,000,000.00 CNY in Q1 2022, reflecting a decrease of 42.9%[28] - The net increase in cash and cash equivalents for Q1 2023 was -31,543,378.63 CNY, compared to -67,881,710.88 CNY in Q1 2022, showing an improvement of about 53.6%[28] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,723,919,580.46, reflecting a 1.10% increase from ¥1,705,232,197.42 at the end of the previous year[3] - The company's current liabilities totaled 286,001,109.05 yuan, slightly decreased from 290,049,952.92 yuan at the start of the year[22] - The company's cash and cash equivalents decreased to 239,818,757.74 yuan from 271,362,136.37 yuan at the beginning of the year[21] - The company's inventory stood at 157,405,681.71 yuan, down from 161,634,522.15 yuan at the start of the year[21] - The company reported goodwill of 435,260,324.85 yuan, an increase from 431,101,990.17 yuan at the beginning of the year[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 18,115[9] - The largest shareholder, Yingcheng Fubon Technology Co., Ltd., holds 30.65% of shares, totaling 88,584,280 shares[9] - The company has a total of 6,021,468 shares under lock-up agreements, with significant releases scheduled for high-level executives[12] - The company has no preferred shareholders as per the report[11] Corporate Developments - The company is in the process of establishing a joint venture with OCP S.A., each contributing $5 million, focusing on value-added fertilizers and digital agriculture[14] - The joint venture has completed registration in Hong Kong and is preparing to establish a wholly-owned subsidiary in Wuhan[14] - The company is actively monitoring a legal dispute regarding the payment for the remaining equity of Holland Novacare, with ongoing judicial processes[15] - The actual controller of the company has changed to Mr. Wang Renzong following a transfer of shares and a divorce settlement with Ms. Fang Shengling[16] - The company plans to acquire 80% of Kangxin Biotechnology for 32 million yuan and will contribute an additional 20 million yuan in registered capital post-acquisition[18] - Kangxin Biotechnology is a high-tech enterprise focused on bio-nitrogen fixation and bio-pesticides, having received multiple national and provincial awards for its contributions[18] - The company is collaborating with China Agricultural University on a project related to nitrogen-fixing bacteria, aiming to enhance green agriculture and food security[19] Miscellaneous - The company received government subsidies amounting to ¥1,265,881.25 during the reporting period, related to provincial technology innovation[4] - The company has not disclosed any other significant matters during the reporting period[13] - The first quarter report for 2023 was not audited[29]

证券代码：300387 证券简称：富邦股份 公告编号：2023-029 湖北富邦科技股份有限公司 关于举行 2022 年度网上业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载，误导性陈述或重大遗漏。 湖北富邦科技股份有限公司（以下简称"公司"）《2022 年年度报告》及其摘 要于 2023 年 4 月 28 日在巨潮资讯网（www.cninfo.com.cn）披露。 三、投资者参与方式 本次业绩说明会将采用网络远程方式举行，投资者可登录"全景·路演天下" （http://rs.p5w.net）参与本次年度业绩说明会。 为充分尊重投资者、提升交流的针对性，现就公司 2022 年度业绩说明会提 前向投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2023 年 5 月 15 日（星期一）15:00 前访问 http://ir.p5w.net/zj/，进入问题征集专题页面。 敬请广大投资者通过全景网系统提交所关注的问题，便于公司在业绩说明会上对 投资者普遍关注的问题进行回答，提升此次业绩说明会的针对性。此次活动交流 期间，投资者仍可登陆活动界面进行互动提问。 特此 ...

Group 1: Company Overview and Financial Performance - The company, Hubei Fubon Technology Co., Ltd., reported significant growth in profit for the first three quarters of 2015, attributed to increased industry recognition and improved sales strategies [1][2]. - The company completed a 55% equity acquisition of Dutch company Novacare by the end of September 2015, with financial data adjustments made in the third quarter report [2][3]. - The overall economic environment for the fertilizer industry improved in 2015 due to the lifting of export tariffs and a recovering global economy [2]. Group 2: Product Development and Market Expansion - Future product development focuses on accelerating technological innovation, creating differentiated products, and exploring overseas markets [1]. - Key products include fertilizer additives, phosphorus wastewater treatment technology, and round granule potassium fertilizer, with the latter expected to commence production in November 2015 [1][2]. - The company aims to expand its market presence in Europe and the Middle East, leveraging the acquisition of Novacare to enhance sales channels and customer resources [2]. Group 3: Strategic Initiatives and Operational Stability - The company plans to maintain operational stability at Novacare by retaining key management and technical personnel post-acquisition [2]. - Efforts will be made to promote Novacare's products in China and Southeast Asia, utilizing the dual-brand strategy for mutual growth [2]. - The company anticipates significant revenue growth in 2016, primarily driven by the integration of Novacare's operations [2].

Group 1: Company Overview - The company primarily sells products to domestic and international fertilizer production enterprises, focusing on phosphate and compound fertilizer manufacturers [1] - Recent growth in sales in Southeast Asia due to the establishment of overseas sales and service teams [1] - Acquisition of Dutch company Novacare has enriched the product line, facilitating better service and products for clients in Europe and Russia [1] Group 2: Investment and Development - The company invested 2 million yuan to establish a joint venture, Hubei Herun Ecological Agriculture Co., Ltd., to diversify its business model [1] - Herun Company develops zinc-enriched rice to enhance crop yield and agricultural product value, targeting infants and pregnant women for nutritional benefits [3] - The company aims to maintain its leading position in the fertilizer additive industry while transitioning towards green and plant nutrition products [3] Group 3: Future Projects and Innovations - Ongoing projects include round granule potassium fertilizer and recovery of slow-release fertilizers from phosphorus wastewater [3] - The company plans to cultivate new profit growth points through innovative projects in the fertilizer additive sector [3]

证券代码：300387 证券简称：富邦股份 湖北富邦科技股份有限公司投资者关系活动记录表 编号：201512-002 | --- | --- | --- | |-------------------------|-------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | 投资者关系活动类 \n别 | ■ \n□ \n□ 现场参观 \n□ | 特定对象调研 □分析师会议 \n媒体采访 □业绩说明会 \n□新闻发布会 □路演活动 \n其他 （请文字说明 ...

证券代码：300387 证券简称：富邦股份 编号：201512-003 | --- | --- | --- | |---------------------------|------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------| | 投资者关系活 \n动类别 | ■ 特定对象调研 □分析师会议 \n□ 媒体采访 □业绩说明会 \n□新闻发布会 □路演活动 \n□ 现场参观 \n□ 其他 （请文字说明其他活动内容） | | | 参与单位名称 | 方正证券：程 磊 | 吴钊华 华泰证券：陈 旸 | | 及人员姓名 | 玖歌投资：江 龙 | 郑 磊 澣伦投资：王柱峰 | | | 光大证券：刘晓波 | 国联安基金：周 楠 | | | 长江证券 ...